Testosterone deficiency syndrome – European Clinical Trials Information Network https://clinicaltrials.eu Bridging Patients with Clinical Trials Fri, 12 Jun 2026 11:23:25 +0000 en-US hourly 1 https://wordpress.org/?v=7.0 https://clinicaltrials.eu/wp-content/uploads/2024/12/cropped-EU_icon-32x32.png Testosterone deficiency syndrome – European Clinical Trials Information Network https://clinicaltrials.eu 32 32 Relative bioavailability and safety of elinzanetant soft‑gel capsules in healthy adults for vasomotor symptoms https://clinicaltrials.eu/trial/relative-bioavailability-and-safety-of-elinzanetant-soft-gel-capsules-in-healthy-adults-for-vasomotor-symptoms/ Fri, 05 Jun 2026 04:02:49 +0000 https://clinicaltrials.eu/trial/relative-bioavailability-and-safety-of-elinzanetant-soft-gel-capsules-in-healthy-adults-for-vasomotor-symptoms/ The study looks at a condition called vasomotor symptoms, which are hot flashes and night sweats that can happen when sex hormones change in women and men. The medication being examined is an oral pill that contains the active ingredient elinzanetant, also known by its code name BAY 3427080, and it is provided in a soft gel capsule form.

The purpose of the study is to compare how much of the medication is absorbed into the bloodstream from different capsule formulations. Participants will take a single dose of each capsule type while fasting, meaning they will not eat for several hours before taking the medicine, and the study will follow a simple schedule where each dose is given at separate times.

Researchers will watch for any adverse events, which are side effects or unwanted reactions, and will record how often they occur and how severe they are, while also measuring how much of the drug reaches the blood to understand its bioavailability.

]]> Study on How Elinzanetant Affects Dabigatran Etexilate in Healthy Volunteers with Vasomotor Symptoms https://clinicaltrials.eu/trial/study-on-how-elinzanetant-affects-dabigatran-etexilate-in-healthy-volunteers-with-vasomotor-symptoms/ Wed, 29 Apr 2026 15:05:18 +0000 https://clinicaltrials.eu/trial/study-on-how-elinzanetant-affects-dabigatran-etexilate-in-healthy-volunteers-with-vasomotor-symptoms/ This clinical trial is focused on understanding how the study drug elinzanetant (also known by its code name BAY 3427080) affects the way another drug, dabigatran etexilate, moves into, through, and out of the body. The study involves healthy male and female participants. Elinzanetant is being studied for its potential effects on vasomotor symptoms, which are symptoms like hot flashes that can occur due to changes in hormone levels in both women and men.

The purpose of the study is to investigate the effect of a single dose of elinzanetant on the exposure of dabigatran etexilate in the body. Participants will receive a single dose of elinzanetant and then the movement of dabigatran etexilate in their bodies will be monitored. The study will help researchers understand how these two drugs interact when taken together.

During the study, participants will be monitored for any side effects or adverse events that may occur. The study aims to ensure the safety of participants while gathering important information about how these drugs work together. This research is important for developing better treatments for managing symptoms related to hormone changes.

]]>